Viewing Study NCT00440167


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-02-22 @ 2:45 PM
Study NCT ID: NCT00440167
Status: UNKNOWN
Last Update Posted: 2012-07-09
First Post: 2007-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
Sponsor: PD Dr. med. Volker Heinemann
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module